http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
Klim and Research Frontiers strike smart glass licensing deal
-
NurExone closes private placement raising C$627,795
-
NurExone Announces Closing of Non-Brokered Private Placement
-
Take Action this Minority Mental Health Awareness Month: Learn How to Prevent Suicide
-
KLIM AND RESEARCH FRONTIERS ENTER INTO LICENSING AGREEMENT
-
Recreatives Industries (OTC: RECX) Places Initial Production Orders for New MAX 4 and Buffalo Truck Platforms
-
Schneider Electric extends EcoCare service plan to 3-phase UPS
-
Cogent Biosciences files NDA for bezuclastinib in advanced mastocytosis
-
Ratio Therapeutics Enters Strategic Actinium-225 Supply Agreement with PanTera to Support Radiopharmaceutical Development Programs
-
Cogent Biosciences Announces Submission of New Drug Application (NDA) for Bezuclastinib in Advanced Systemic Mastocytosis (AdvSM)
-
Element One Invited to Help Shape British Columbia's Hydrogen Strategy
-
Max Power Confirms Basin-Scale Natural Hydrogen Potential in Saskatchewan with Bracken Well, 325 Km from Lawson Discovery
-
American Lithium Minerals, Inc. (OTC: AMLM) Acquires 100% Interest in High Grade New Zealand Gold–Antimony Projects
-
Schneider Electric expands EcoCare services to 3-Phase UPS, delivering AI-powered condition-based maintenance to help organizations maximize uptime and reduce risk
-
Star Copper Expands Copper-Gold Portfolio with Two Advanced District-Scale Exploration Assets in British Columbia
-
Palvella Therapeutics adds Matt Pauls to its board of directors
-
Brixton Metals Drills 14.75m of 1.25% Copper, 1.71 g/t Gold, 149.0 g/t Silver at the Near Surface Glenfiddich Zone, Camp Creek Corridor
-
Palvella Therapeutics Appoints Accomplished Rare Disease Biotech Executive and Commercial Leader Matt Pauls, J.D., M.B.A., to Board of Directors
-
Silver Wolf Reports Contact Skarn Intercepts From the Ongoing Drill Program at the Ana Maria Property
-
Novocure's Optune Pax wins CE Mark for pancreatic cancer
-
Novocure’s Optune Pax® Receives CE Mark for the Treatment of Locally Advanced Pancreatic Cancer
-
Surge Battery Metals Announces Filing of Updated Mineral Resource Estimate Technical Report
-
Eminent Reports Airborne Geophysical Survey Results at Hot Springs Range
-
JCPenney Turns Gas Receipts Into Savings for Families Ahead of Fourth of July Weekend
-
Google News Exposure Helps Businesses Reach Audiences Beyond Traditional Marketing
-
Apex Mobilizes Drill Rig and Commences 2026 Exploration Program at the Cap Critical Minerals Project
-
Just - Evotec Biologics Launches J.TRAIN to Deliver Turnkey Continuous Manufacturing for Biologics
-
Best Crypto to Invest In for 2026: Why Bullski’s Meme Presale and Priority List Lead
-
ThreatCluster Announces Cyber Threat Intelligence Platform Designed to Reduce Security Alert Noise Through Semantic Clustering and Tailored Intelligence
-
Tapbit Integrates Mercuryo to Strengthen Fiat Payment Infrastructure for Global Users
-
MedMira Reports Third Quarter Results FY2026
-
ASUS Education and Intel Showcase AI-Ready Technology for K-12 Schools at ISTE+ASCD 2026
-
AbraSilver Announces Results of Annual General Meeting
-
Visionstate Announces LIFE Financing of Up to $1.0 Million to Accelerate Commercial Growth of MIRA Compliance Intelligence Platform
-
PENSKE TEAMSTERS IN FLORIDA AND MISSOURI AUTHORIZE A STRIKE
-
FDA extends review of Praxis drug for rare epilepsy to December 2026
-
Praxis Precision Medicines Announces Extension Period for Relutrigine for Treatment of SCN2A and SCN8A Developmental and Epileptic Encephalopathies
-
Strategic Resources Inc. to supply concentrate to the €17 million FutSteel project in Finland
-
Norwegian Cruise Line names Lee Applbaum as chief marketing officer
-
AbbVie's epcoritamab combo meets primary endpoint in lymphoma trial
-
Norwegian Cruise Line Names Lee Applbaum as Chief Marketing Officer
-
AbbVie Announces Positive Phase 3 Results for Epcoritamab Plus Lenalidomide in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma
-
Digital Realty to buy Blackstone's stake in 3 Virginia data centers
-
Digital Realty Announces Purchase of Blackstone Interest in Three Northern Virginia Data Centers
-
DBV Technologies Provides BLA Submission Update for the VIASKIN® Peanut Patch in Children Aged 4 through 7 Years; Working Collaboratively with FDA to Optimize Review Process in Preparation for Filing
-
As America Turns 250, Rediscover the Family Tradition That Built a Lifetime of Memories
-
Next Bridge Hydrocarbons Answers Frequently Asked Questions Regarding the Upcoming Special Dividend of Common Stock
-
AHF: Florida Budget Becomes Law, Securing Reversal of HIV Drug Cuts
-
NHRA ROOKIE SENSATION MADDI GORDON ROLLS TO FIRST TOP FUEL WIN IN NORWALK
-
Prime Healthcare Hospitals Named to Becker’s “100 Great Community Hospitals” List

